Abstract:Human structural congenital malformations are the leading cause of infant mortality in the United States. Estimates from the United States Center for Disease Control and Prevention (CDC) determine that close to 3% of all United States newborns present with birth defects; the worldwide estimate approaches 6% of infants presenting with congenital anomalies. The scientific community has recognized for decades that the majority of birth defects have undetermined etiologies, although we propose that environmental agents interacting with inherited susceptibility genes are the major contributing factors. Neural tube defects (NTDs) are among the most prevalent human birth defects and as such, these malformations will be the primary focus of this review. NTDs result from failures in embryonic central nervous system development and are classified by their anatomical locations. Defects in the posterior portion of the neural tube are referred to as meningomyeloceles (spina bifida), while the more anterior defects are differentiated as anencephaly, encephalocele, or iniencephaly. Craniorachischisis involves a failure of the neural folds to elevate and thus disrupt the entire length of the neural tube. Worldwide NTDs have a prevalence of approximately 18.6 per 10,000 live births. It is widely believed that genetic factors are responsible for some 70% of NTDs, while the intrauterine environment tips the balance toward neurulation failure in at risk individuals. Despite aggressive educational campaigns to inform the public about folic acid supplementation and the benefits of providing mandatory folic acid food fortification in the United States, NTDs still affect up to 2,300 United States births annually and some 166,000 spina bifida patients currently live in the United States, more than half of whom are now adults. Within the context of this review, we will consider the role of maternal nutritional status (deficiency states involving B vitamins and one carbon analytes) and the potential modifiers of NTD risk beyond folic acid. There are several well-established human teratogens that contribute to the population burden of NTDs, including: industrial waste and pollutants [e.g., arsenic, pesticides, and polycyclic aromatic hydrocarbons (PAHs)], pharmaceuticals (e.g., anti-epileptic medications), and maternal hyperthermia during the first trimester. Animal models for these teratogens are described with attention focused on valproic acid (VPA; Depakote). Genetic interrogation of model systems involving VPA will be used as a model approach to discerning susceptibility factors that define the gene-environment interactions contributing to the etiology of NTDs.

Maternal factors for neural tube defects in offspring: An umbrella review

Maternal body mass index and the association between folic acid supplements and neural tube defects.

Periconceptional Factors Affect the Risk of Neural Tube Defects in Offspring: a Hospital-Based Case-Control Study in China.

Effects of Folic Acid Supplementation During Different Pregnancy Periods and Relationship with the Other Primary Prevention Measures to Neural Tube Defects

Nausea and Vomiting in Early Pregnancy and the Risk of Neural Tube Defects: a Case-Control Study.

Maternal Flu or Fever, Medications Use in the First Trimester and the Risk for Neural Tube Defects: a Hospital-Based Case–control Study in China

Nutrition, One-Carbon Metabolism and Neural Tube Defects: A Review

High Ratios Of C20:4n-6/C20:5n-3 And Thromboxane B-2/6-Keto-Prostaglandin F-1 Alpha In Placenta Are Potential Risk Contributors For Neural Tube Defects: A Case-Control Study In Shanxi Province, China

Gene Environment Interactions in the Etiology of Neural Tube Defects

High Ratios of C20:4n-6/C20:5n-3 and Thromboxane B2 /6-Keto-prostaglandin F1α in Placenta Are Potential Risk Contributors for Neural Tube Defects: A Case-Control Study in Shanxi Province, China.

Risk factors for neural-tube defects detected in utero: A prospective community-based study from Addis Ababa

Maternal Flu Or Fever, Medication Use, And Neural Tube Defects: A Population-Based Case-Control Study In Northern China

Pre-conception folic acid and multivitamin supplementation for the prevention of Neural Tube Defect: An umbrella Review

Maternal Periconceptional Body Mass Index and Risk for Neural Tube Defects: Results from a Large Cohort Study in China.

Association Of The Maternal Mthfr C677t Polymorphism With Susceptibility To Neural Tube Defects In Offsprings: Evidence From 25 Case-Control Studies

Markers of macromolecular oxidative damage in maternal serum and risk of neural tube defects in offspring.

Maternal Prepregnancy Body Mass Index and Risk of Neural Tube Defects: A Population-Based Case-Control Study in Shanxi Province, China.

The causes of neural tube defect:evidence-based research

Determinants of neural tube defects among women who gave birth in hospitals in Eastern Ethiopia: evidence from a matched case control study

Indoor Air Pollution and Neural Tube Defects: Effect Modification by Maternal Genes.

Factors Associated with Neural Tube Defects among Women Who Gave Birth at Adama Hospital Medical College, Adama, Ethiopia: A Case Control Study